FMR LLC & Abigail Johnson Hold 9.53% Stake in Boston Scientific
Ticker: BSX · Form: SC 13G/A · Filed: Feb 9, 2024 · CIK: 885725
| Field | Detail |
|---|---|
| Company | Boston Scientific CORP (BSX) |
| Form Type | SC 13G/A |
| Filed Date | Feb 9, 2024 |
| Risk Level | low |
| Sentiment | neutral |
Complexity: simple
Sentiment: neutral
Topics: institutional-ownership, amendment, passive-investment
TL;DR
**FMR LLC and Abigail Johnson still own nearly 10% of Boston Scientific, showing strong institutional backing.**
AI Summary
FMR LLC, a major investment firm, and its CEO, Abigail P. Johnson, have updated their ownership stake in Boston Scientific Corp. As of February 9, 2024, they collectively beneficially own 139,602,739 shares of common stock, representing 9.529% of the company. This filing indicates a significant, but passive, institutional investment, which can signal confidence in Boston Scientific's long-term prospects to current and potential shareholders.
Why It Matters
This filing shows a major institutional investor, FMR LLC, and its leader, Abigail P. Johnson, maintain a substantial stake in Boston Scientific, which can be a positive signal of confidence for other investors.
Risk Assessment
Risk Level: low — This filing is an update to a passive investment, indicating no immediate change in control or strategy, thus posing low risk.
Analyst Insight
A smart investor would view this as a confirmation of continued institutional interest in Boston Scientific, but it doesn't suggest any immediate catalysts for price movement. It's a data point for long-term conviction rather than short-term trading.
Key Numbers
- 139,602,739 — Shares Beneficially Owned (Total common stock shares owned by FMR LLC and Abigail P. Johnson in Boston Scientific Corp.)
- 9.529% — Percent of Class (The percentage of Boston Scientific Corp.'s common stock beneficially owned by FMR LLC and Abigail P. Johnson.)
- 0 — Sole Power to Vote (Abigail P. Johnson) (Abigail P. Johnson reports no sole voting power over the shares, indicating shared or indirect control.)
- 131,472,153 — Sole Power to Vote (FMR LLC) (FMR LLC reports sole voting power over a significant portion of its beneficially owned shares.)
- 20240209 — Date of Filing (The date this amendment to the Schedule 13G was filed with the SEC.)
Key Players & Entities
- FMR LLC (company) — reporting person and parent holding company
- Abigail P. Johnson (person) — reporting person, likely CEO of FMR LLC
- BOSTON SCIENTIFIC CORP (company) — the issuer of the securities
- Delaware (company) — state of incorporation for FMR LLC
- United States of America (person) — citizenship of Abigail P. Johnson
Forward-Looking Statements
- FMR LLC will maintain a significant, passive stake in Boston Scientific Corp. for the foreseeable future. (FMR LLC) — high confidence, target: 2025-02-09
- Boston Scientific Corp.'s stock price will likely not be significantly impacted by this passive ownership update alone. (BOSTON SCIENTIFIC CORP) — medium confidence, target: 2024-03-09
FAQ
Who are the reporting persons in this SC 13G/A filing?
The reporting persons are FMR LLC and Abigail P. Johnson, as stated in Item 1 of the filing for both entities.
What percentage of Boston Scientific Corp.'s common stock do the reporting persons beneficially own?
FMR LLC and Abigail P. Johnson each beneficially own 9.529% of Boston Scientific Corp.'s common stock, as indicated in Item 11 for both reporting persons.
How many shares of Boston Scientific Corp. common stock are beneficially owned by FMR LLC and Abigail P. Johnson?
Both FMR LLC and Abigail P. Johnson beneficially own 139,602,739 shares of Boston Scientific Corp. common stock, as reported in Item 7 for both.
What is the CUSIP number for Boston Scientific Corp. common stock mentioned in the filing?
The CUSIP number for Boston Scientific Corp. common stock is 101137107, as stated in the 'Cusip #101137107' section of the filing.
Under which rule is this Schedule 13G filed?
This Schedule 13G is filed pursuant to Rule 13d-1(b), as indicated by the checked box '[x] Rule 13d-1(b)' and further confirmed in Item 3 of the filing.
Filing Details
This Form SC 13G/A (Form SC 13G/A) was filed with the SEC on February 9, 2024 by Abigail P. Johnson regarding BOSTON SCIENTIFIC CORP (BSX).